US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 2.070
  • +0.050+2.48%
Close Apr 26 16:00 ET
  • 2.060
  • -0.010-0.48%
Post 16:00 ET
32.62MMarket Cap-1800P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
17.31%-2.18M
-503.58%-1.99M
-242.88%-1.88M
Net income from continuing operations
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
Other non cash items
29.93%559.58K
240.85%393.68K
--0
--0
-11.80%165.9K
-72.87%430.68K
32.00%115.5K
-90.43%127.08K
--0
38.85%188.1K
Change In working capital
-19.02%1.01M
-132.56%-310.15K
-64.99%188.19K
1,323.61%1.06M
145.57%70.65K
783.42%1.25M
159.70%952.46K
138.61%537.5K
-105.85%-86.8K
51.05%-155.03K
-Change in receivables
---129.16K
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
424.50%159.18K
-100.07%-54
92.86%-15.78K
-4.84%116.66K
4.48%58.35K
112.30%30.35K
-69.04%72.85K
-18.77%-220.95K
1,259.48%122.6K
118.31%55.85K
-Change in payables and accrued expense
-19.46%980.75K
-120.57%-180.94K
-71.20%203.97K
694.05%945.43K
105.83%12.3K
213.88%1.22M
569.04%879.61K
158.71%708.2K
-110.79%-159.15K
-1,694.12%-210.88K
Cash from discontinued investing activities
Operating cash flow
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
17.31%-2.18M
-503.58%-1.99M
-242.88%-1.88M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
120.92%8.16M
461,963,800.00%4.62M
0
-75.03%3.7M
-1
3.7M
Net common stock issuance
60.86%5.94M
----
----
----
----
-75.03%3.7M
----
----
----
----
Proceeds from stock option exercised by employees
17,069,684.62%2.22M
--2.22M
--0
----
----
--13
--0
--13
----
----
Cash from discontinued financing activities
Financing cash flow
120.92%8.16M
461,963,800.00%4.62M
--0
----
----
-75.03%3.7M
---1
--3.7M
----
----
Net cash flow
Beginning cash position
-29.69%9.11M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
308.10%12.96M
-26.64%10.61M
-46.82%9.09M
321.68%11.08M
308.10%12.96M
Current changes in cash
57.43%-1.64M
128.21%421.86K
-238.17%-2.09M
198.81%1.97M
-3.03%-1.93M
-139.32%-3.85M
0.31%-1.5M
157.47%1.52M
-113.76%-1.99M
-242.88%-1.88M
End cash Position
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
321.68%11.08M
Free cash flow
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
17.31%-2.18M
-503.58%-1.99M
-242.88%-1.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M17.31%-2.18M-503.58%-1.99M-242.88%-1.88M
Net income from continuing operations -20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M34.55%-2.62M-81.11%-2.67M
Other non cash items 29.93%559.58K240.85%393.68K--0--0-11.80%165.9K-72.87%430.68K32.00%115.5K-90.43%127.08K--038.85%188.1K
Change In working capital -19.02%1.01M-132.56%-310.15K-64.99%188.19K1,323.61%1.06M145.57%70.65K783.42%1.25M159.70%952.46K138.61%537.5K-105.85%-86.8K51.05%-155.03K
-Change in receivables ---129.16K------------------0----------------
-Change in prepaid assets 424.50%159.18K-100.07%-5492.86%-15.78K-4.84%116.66K4.48%58.35K112.30%30.35K-69.04%72.85K-18.77%-220.95K1,259.48%122.6K118.31%55.85K
-Change in payables and accrued expense -19.46%980.75K-120.57%-180.94K-71.20%203.97K694.05%945.43K105.83%12.3K213.88%1.22M569.04%879.61K158.71%708.2K-110.79%-159.15K-1,694.12%-210.88K
Cash from discontinued investing activities
Operating cash flow -29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M17.31%-2.18M-503.58%-1.99M-242.88%-1.88M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 120.92%8.16M461,963,800.00%4.62M0-75.03%3.7M-13.7M
Net common stock issuance 60.86%5.94M-----------------75.03%3.7M----------------
Proceeds from stock option exercised by employees 17,069,684.62%2.22M--2.22M--0----------13--0--13--------
Cash from discontinued financing activities
Financing cash flow 120.92%8.16M461,963,800.00%4.62M--0---------75.03%3.7M---1--3.7M--------
Net cash flow
Beginning cash position -29.69%9.11M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M308.10%12.96M-26.64%10.61M-46.82%9.09M321.68%11.08M308.10%12.96M
Current changes in cash 57.43%-1.64M128.21%421.86K-238.17%-2.09M198.81%1.97M-3.03%-1.93M-139.32%-3.85M0.31%-1.5M157.47%1.52M-113.76%-1.99M-242.88%-1.88M
End cash Position -17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M-26.64%10.61M-46.82%9.09M321.68%11.08M
Free cash flow -29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M17.31%-2.18M-503.58%-1.99M-242.88%-1.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg